Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders

Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders

US Patent 7250407 · Granted Jul 31, 2007

Estimated economic value: $138,124,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CER-001 therapy for treating kidney disease2025
Lipoprotein complexes and manufacturing and uses thereof2025
Compounds useful for treating liver diseases2025
Complexes for delivery of cyclic dinucleotides2025
Lipoprotein complexes and manufacturing and uses thereof2024
Lipoprotein complexes and manufacturing and uses thereof2024
Charged lipoprotein complexes and their uses2023
CER-001 therapy for treating kidney disease2023
Compounds useful for treating liver diseases2023
Lipoprotein complexes and manufacturing and uses thereof2022
Hydroxyl compounds and compositions for cholesterol management and related uses2021
Lipoprotein complexes and manufacturing and uses thereof2019